Clinical Trial Update: Evaluation of RBS2418 in Patients With Advanced, Metastatic, and Progressive Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating RBS2418 in patients with advanced, metastatic colorectal cancer; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• RBS2418

Snippet

Sponsor: Riboscience, LLC. | Conditions: Metastatic Colorectal Cancer, Advanced Colorectal Cancer | Phase 2 | Status: RECRUITING